✦ LIBER ✦

Combination therapy with liraglutide and sulfonylurea for a type 2 diabetic patient with high titer of anti-insulin antibodies produced by insulin therapy

✍ Scribed by Masanori Yoshida; Masato Asai; Misaki Miyata; Koichiro Ogawa; Harumi Maeda; Yutaka Oiso

Book ID: 116407398
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 113 KB
Volume: 96
Category: Article
ISSN: 0168-8227
DOI: 10.1016/j.diabres.2011.12.024

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combined metformin and insulin therapy f

Combined metformin and insulin therapy for patients with type 2 diabetes mellitus

✍ Huibert Hendrik Ponssen; Jan Willem Frederik Elte; Philippe Lehert; Jan Pieter S 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 740 KB

Liraglutide vs insulin glargine and plac

Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial

✍ D. Russell-Jones; A. Vaag; O. Schmitz; B. K. Sethi; N. Lalic; S. Antic; M. Zdrav 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 193 KB

Effect of pioglitazone in combination wi

Effect of pioglitazone in combination with insulin therapy on glycaemic control, insulin dose requirement and lipid profile in patients with type 2 diabetes previously poorly controlled with combination therapy

✍ P. Berhanu; A. Perez; S. Yu 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB

A case of glycemic instability and insul

A case of glycemic instability and insulin allergy due to anti-insulin antibodies in a patient with type 2 diabetes

✍ Katsumi Iizuka, Reiko Tomita, Yukio Horikawa, Jun Takeda 📂 Article 📅 2012 🏛 Springer Japan 🌐 English ⚖ 240 KB

A combination of once daily insulin and

A combination of once daily insulin and glibenclamide therapy in patients with type 2 diabetes and secondary drug failure

✍ Fonseca, V A ;D'Souza, V. ;Bell, J L ;Dandona, P 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 434 KB

## Abstract Twenty eight patients with non‐insulin‐dependent diabetes mellitus (NIDDM) who were not adequately controlled with maximum doses of sulphonylureas and metformin (Group I; n=13) or with insulin injections (Group II; n=15) were treated with a combination of insulin injections in the morni

Switching to three pre-meal injections o

Switching to three pre-meal injections of insulin glulisine from the basal-bolus insulin therapy improves glycemic control in a patient with type 2 diabetes who had anti-insulin antibody

✍ Hidekatsu Yanai; Taro Yoshimi; Hidetaka Hamasaki 📂 Article 📅 2011 🏛 Medknow Publications 🌐 English ⚖ 47 KB